Literature DB >> 8100351

Expression of the antisense cDNA for protein kinase C alpha attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells.

S Ahmad1, R I Glazer.   

Abstract

Multidrug resistance is functionally associated with the expression of a plasma membrane energy-dependent drug efflux pump termed P-glycoprotein, the product of the mdr1 gene. Transfection of P-glycoprotein-expressing doxorubicin-resistant MCF-7 cells with an expression vector containing the cDNA for protein kinase C alpha in the antisense orientation reduces protein kinase C alpha levels and decreases total protein kinase C activity by 75%. This is accompanied by reduced phosphorylation of P-glycoprotein, a 2-fold increase in drug retention, and a 3-fold increase in doxorubicin cytotoxicity. These results provide further evidence that protein kinase C alpha can positively regulate multidrug resistance in MCF-7 cells through posttranslational phosphorylation of P-glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100351

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  21 in total

Review 1.  Protein kinase C inhibitors.

Authors:  Helen C Swannie; Stanley B Kaye
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.075

Review 2.  Classical Protein Kinase C: a novel kinase target in breast cancer.

Authors:  R K Singh; S Kumar; M S Tomar; P K Verma; S P Singh; P K Gautam; A Acharya
Journal:  Clin Transl Oncol       Date:  2018-07-30       Impact factor: 3.405

Review 3.  Effects of phosphorylation of P-glycoprotein on multidrug resistance.

Authors:  U A Germann; T C Chambers; S V Ambudkar; I Pastan; M M Gottesman
Journal:  J Bioenerg Biomembr       Date:  1995-02       Impact factor: 2.945

Review 4.  Protein kinase C isozymes and substrates in mammary carcinogenesis.

Authors:  S C Kiley; J Welsh; C J Narvaez; S Jaken
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

5.  Evaluation of 2,6-diamino-N-([1-(1-oxotridecyl)-2-piperidinyl]methyl)- hexanamide (NPC 15437), a protein kinase C inhibitor, as a modulator of P-glycoprotein-mediated resistance in vitro.

Authors:  E C Sha; M C Sha; S H Kaufmann
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

Review 6.  Regulation of protein kinase C and role in cancer biology.

Authors:  G C Blobe; L M Obeid; Y A Hannun
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

7.  Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides.

Authors:  N M Dean; R McKay
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

Review 8.  Clinical significance of cellular resistance in tumours to cytotoxic chemotherapy and radiotherapy.

Authors:  M Pomeroy; M Moriarty
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 9.  Role of protein kinases in antitumor drug resistance.

Authors:  H Grunicke; J Hofmann; I Utz; F Uberall
Journal:  Ann Hematol       Date:  1994       Impact factor: 3.673

10.  Molecular analysis of the multidrug transporter, P-glycoprotein.

Authors:  U A Germann; T C Chambers
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.